Charles River Labs sees FY13 net sales growth 3%-5% ex-Vital River Including Vital River, sees net sales growth 4%-6% in constant currency. Sees FY13 free cash flow $165M-$175M, CapEx $50M.
News For CRL From The Last 14 Days
Check below for free stories on CRL the last two weeks.